BAJAJ FINSERV TRIANGLE PATTERN As we can see, BAJAJ FINSERV was forming a symmetrical triangle pattern on a weekly time frame and has currently broken out of it. We can consider a buy on pullback at around 1835.by Kartik_Elkunchwar4
Darvas Box Strategy - Breakout StockDisclaimer: I am Not SEBI Registered adviser, please take advise from your financial adviser before investing in any stocks. Idea here shared is for education purpose only. Stock has given break out. Buy above high. Keep this stock in watch list. Buy above the High and do not forget to keep stop loss, best suitable for swing trading. Target and Stop loss Shown on Chart. Risk to Reward Ratio/ Target Ratio 1:1 & 1:2. Stop loss can be Trail when it make new box. Be Discipline, because discipline is the key to Success in Stock Market. Trade what you See Not what you Think.by AnsariTV0
NuCana Stock Surges 185% on Promising Melanoma Treatment ResultsNuCana plc (NASDAQ: NASDAQ:NCNA ) saw its stock skyrocket by 185% after presenting final data from its Phase 2 NuTide:701 study at the European Society for Medical Oncology (ESMO) Congress. This significant surge comes after a tough stretch for the company, especially following disappointing results from its colorectal cancer treatment. Investors are optimistic about the company’s potential, but does this rally indicate a sustainable uptrend? Let's explore the fundamental and technical aspects of NASDAQ:NCNA to assess the stock's future potential. A Breakthrough in Melanoma Treatment NuCana’s recent surge is largely driven by positive data from its Phase 2 study on NUC-7738, in combination with Merck’s Keytruda (pembrolizumab), for treating metastatic melanoma patients who have been resistant or relapsed after prior PD-1 inhibitor therapy. In a small 12-patient cohort, the combination therapy showed remarkable efficacy: - 75% of patients achieved disease control, including two partial responses. - One patient, who had relapsed after two prior PD-1-based treatments, saw a **55% reduction in tumor volume. - 7 out of 12 patients experienced progression-free survival of over five months, which is impressive compared to the median progression-free survival of just 2-3 months with the current standard treatments for this patient group. These data highlight the potential of NUC-7738 to sensitize PD-1-resistant tumors, a major breakthrough in the melanoma treatment landscape. Hugh Griffith, NuCana's CEO, expressed excitement over the results, noting the promising signals from NUC-7738 combined with pembrolizumab and its potential to extend progression-free survival in patients with poor outcomes from existing therapies. This positive news follows the company’s decision to discontinue its NuTide:323 study for colorectal cancer, which led to a sharp decline in investor confidence earlier. However, the success of NUC-7738 in resistant melanoma has revived hope, with the company's strong potential to tap into new cancer therapies. Technical Analysis: Is NASDAQ:NCNA 's Rally Sustainable? From a technical perspective, NASDAQ:NCNA has rebounded sharply from its all-time low, showing a massive **183% surge**. However, while the upward momentum is strong, investors need to be cautious of potential pullbacks and overbought conditions. - RSI (Relative Strength Index): The RSI is currently at **58**, signaling that the stock is approaching overbought territory. Typically, an RSI over 70 suggests an overbought market, where a correction or profit-taking might occur. Although the current level does not suggest immediate danger, it’s important to monitor this metric as the stock continues to climb. - Falling Trend Channel: Despite the recent surge, NASDAQ:NCNA has been on a **long-term downtrend**, caught in a falling trend channel for several months. The stock had been oversold for an extended period, which might have attracted bargain hunters and speculators once the positive data hit the market. The current breakout is a significant departure from this trend, but the question remains whether this is a temporary surge or the start of a sustained reversal. - Key Support and Resistance Levels: The recent surge places NASDAQ:NCNA in uncharted territory. Immediate support may be found near the **$4.50-$5.00 range**, which was resistance prior to the breakout. If the rally continues, resistance is likely around the **$7.00-$7.50 level**, which aligns with historical highs and could serve as a psychological barrier. - Volume and Momentum: Trading volume has surged alongside the price increase, indicating strong buying interest. However, it’s crucial for the stock to maintain this momentum in the coming sessions. A sudden drop in volume might suggest fading interest, leading to a potential reversal. What’s Next for NuCana? While the technical aspects indicate that NASDAQ:NCNA is nearing overbought levels, the stock’s recent surge is supported by strong fundamentals. The company’s promising data from the NuTide:701 study positions NuCana as a potential leader in melanoma treatment, particularly for patients who have no other options after failing prior PD-1 inhibitor therapies. However, investors should remain cautious about the stock’s volatility and the possibility of profit-taking. Despite the positive developments in melanoma treatment, NuCana still faces significant challenges. The discontinuation of the NuTide:323 study for colorectal cancer left a stain on investor confidence. For long-term investors, the question remains whether NuCana can build on its success in melanoma and expand its pipeline to other cancer treatments. Conclusion: A Compelling but Cautious Buy NuCana's recent rally is backed by encouraging clinical results, making it a potentially strong buy for risk-tolerant investors. However, the stock's technical indicators suggest that it could face short-term resistance as it approaches overbought territory. Investors should closely watch the stock’s price action and fundamental developments to determine whether this surge is part of a larger upward trend or merely a short-lived bounce. While NASDAQ:NCNA has shown resilience in the face of setbacks, it remains a high-risk, high-reward play. Investors should consider taking profits as the stock approaches resistance levels or if trading volume starts to fade. As always, thorough research and close monitoring of both technical and fundamental indicators are essential to making informed investment decisions in a volatile stock like $NCNA.Longby DEXWireNews1
Darvas Box Strategy - Breakout Stockisclaimer: I am Not SEBI Registered adviser, please take advise from your financial adviser before investing in any stocks. Idea here shared is for education purpose only. Stock has given break out. Buy above high. Keep this stock in watch list. Buy above the High and do not forget to keep stop loss, best suitable for swing trading. Target and Stop loss Shown on Chart. Risk to Reward Ratio/ Target Ratio 1:1 & 1:2. Stop loss can be Trail when it make new box. Be Discipline, because discipline is the key to Success in Stock Market. Trade what you See Not what you Think.by AnsariTV0
TIME TO BUY ICICI BANK ?ICICI BANK has recently surpassed the 1250 resistance level, which also marked an all-time high for the stock. It is currently trading above this level. You can consider entering now or wait for a pullback to 1250-1255 for a potentially better entry point.Longby Kartik_Elkunchwar2
$SFM Continuing HigherNASDAQ:SFM continuing higher from breakout supported by earnings. Longby krsnead20
Breakdown in BELStock may test the marked target. In BEL . For study purpose only by abhijitbhalerao791
Darvas Box Startegy - Breakout StockDisclaimer: I am Not SEBI Registered adviser, please take advise from your financial adviser before investing in any stocks. Idea here shared is for education purpose only. Stock has given break out. Buy above high. Keep this stock in watch list. Buy above the High and do not forget to keep stop loss, best suitable for swing trading. Target and Stop loss Shown on Chart. Risk to Reward Ratio/ Target Ratio 1:1 & 1:2. Stop loss can be Trail when it make new box. Be Discipline, because discipline is the key to Success in Stock Market. Trade what you See Not what you Think.by AnsariTV0
United Polyfab Gujarat LtdUnited Polyfab Gujarat Ltd Incorporated in 2010, United Polyfab Gujarat Ltd is in the business of Fabrics Manufacturing and Spinning & Weaving of Yarn. UPGL does trading and manufacturing of woven fabrics and yarn. It also does job work of manufacturing/ weaving of gray denim, gray fabric, and gray cotton fabric. Company derives all its sales from Gujarat.Longby sushithengoor1
Darvas Box Strategy - Breakout Stockisclaimer: I am Not SEBI Registered adviser, please take advise from your financial adviser before investing in any stocks. Idea here shared is for education purpose only. Stock has given break out. Buy above high. Keep this stock in watch list. Buy above the High and do not forget to keep stop loss, best suitable for swing trading. Target and Stop loss Shown on Chart. Risk to Reward Ratio/ Target Ratio 1:1. Stop loss can be Trail when it make new box. Be Discipline, because discipline is the key to Success in Stock Market. Trade what you See Not what you Think.by AnsariTV0
Review and plan for 17th September 2024 Nifty future and banknifty future analysis and intraday plan in kannada. Positional trading ideas included. This video is for information/education purpose only. you are 100% responsible for any actions you take by reading/viewing this post. please consult your financial advisor before taking any action. ----Vinaykumar hiremath, CMTLong09:12by vinaysh0
RKLB Breakout IncomingA long consolidation period is concluding for a major breakout to (and above) $8 LEAPS, ATM Calls, or equity would suffice. Big rotation opportunityLongby Eclipse_TradingUpdated 14
Bajaj AutoBajaj Auto is a 12,000 future value stock. currently trading around 9500 levels Right entry is 9350 levels and can add in every dip Short Term Stop Loss - 9000 levels Target levels Short Term - 10,045 Long Term Targets - 10,463 / 11,129 / 11,809 This idea is just for education purpose and analysis and not for real time trading kindly consult your financial adviser before investing Longby haresh2408Updated 10
Darvas Box Strategy-Breakout Stockisclaimer: I am Not SEBI Registered adviser, please take advise from your financial adviser before investing in any stocks. Idea here shared is for education purpose only. Stock has given break out. Buy above high. Keep this stock in watch list. Buy above the High and do not forget to keep stop loss, best suitable for swing trading. Target and Stop loss Shown on Chart. Risk to Reward Ratio/ Target Ratio 1:1 & 1:2. Stop loss can be Trail when it make new box. Be Discipline, because discipline is the key to Success in Stock Market. Trade what you See Not what you Think.by AnsariTV0
PLTR Back to ATHsBounced off the .382 fib retracement with only ATH remaining. Lots of bullish momentum and TA has been smooth as well. Possible S&P 500 inclusion in September could also be driving price action from "smart money." Flow into calls has been increasing with a few big orders above ATH have been spottedLongby Eclipse_TradingUpdated 1110
Darvas Box Startegy - Breakout StockDisclaimer: I am Not SEBI Registered adviser, please take advise from your financial adviser before investing in any stocks. Idea here shared is for education purpose only. Stock has given break out. Buy above high. Keep this stock in watch list. Buy above the High and do not forget to keep stop loss, best suitable for swing trading. Target and Stop loss Shown on Chart. Risk to Reward Ratio/ Target Ratio 1:1 & 1:2. Stop loss can be Trail when it make new box. Be Discipline, because discipline is the key to Success in Stock Market. Trade what you See Not what you Think.by AnsariTV1
ACHR NYSE --On a Close Trend of spiking as could break 200MA 4.8This is one of many Electric Aviation company's with some nice numbers moving up to 4.8$ which is a shows (me?) 200MA..thus could be a nice Swing. I'm in from 5.10$ as for this trade..will wait some days, As it also shows fast dumps..so need an eye on it, But for me looks like Tree Shaking.. Good luck if helps anyoneLongby WildstarUpdated 229
Darvas Box Strategy - Breakout StockDisclaimer: I am Not SEBI Registered adviser, please take advise from your financial adviser before investing in any stocks. Idea here shared is for education purpose only. Stock has given break out. Buy above high. Keep this stock in watch list. Buy above the High and do not forget to keep stop loss, best suitable for swing trading. Target and Stop loss Shown on Chart. Risk to Reward Ratio/ Target Ratio 1:1 & 1:2. Stop loss can be Trail when it make new box. Be Discipline, because discipline is the key to Success in Stock Market. Trade what you See Not what you Think.by AnsariTV0
JNJ LongDemand Zone Long 152.40 Stop 145 Target 162, 173 Risk management is much more important than a good entry point. I am not a PRO trader. In my trading plan, the Max Risk of each short term trade should be less than 1% of an account. Longby PlanTradePlanMMUpdated 2
Apple's iPhone 16 Pre-Order Struggles: A Buying Opportunity?Apple Inc. (NASDAQ: NASDAQ:AAPL ) has always been a tech behemoth, but its latest iPhone 16 launch appears to be facing some turbulence. Analysts are reporting weaker-than-expected pre-orders, with the first weekend sales estimated at around 37 million units, a 12.7% dip compared to last year. But could this moment of weakness actually present an opportunity for investors? Let's dive into the technical and fundamental aspects of Apple's current standing. Weak iPhone 16 Pre-Orders and AI Lag The most significant concern surrounding Apple’s recent performance stems from the iPhone 16’s pre-orders. Analysts, including Ming-Chi Kuo from TF International Securities, project a 12.7% decline in pre-orders compared to last year, underscoring a drop in demand for Apple’s latest flagship device. This decline in demand is primarily attributed to Apple’s sluggish pace in the artificial intelligence (AI) race. While AI innovation has taken center stage in tech, Apple has yet to make significant strides in this area. The lack of AI features in the iPhone 16 has left many potential buyers underwhelmed, especially in China, where local competitors like Huawei are ahead in integrating cutting-edge AI into their devices. In fact, Apple has been knocked out of the top five smartphone sellers in China for the first time—a sobering signal of the challenges ahead. The AI sector is rapidly expanding, and Apple’s reliance on OpenAI’s technology for AI features in its iPhones is becoming a liability, especially given the Chinese government’s stringent policies against foreign AI technologies. If Apple does not address this gap soon, its position in the global smartphone market could face more significant challenges. Despite these obstacles, Apple is not out of the race. The company has a history of overcoming setbacks and bouncing back stronger. Apple's short-term hurdles might be part of a larger, strategic approach. Many analysts speculate that Apple could be holding back major feature releases for the holiday season, a time when consumer spending surges. If enhanced AI capabilities are introduced in the coming months, especially in tandem with the shopping season, Apple could see a significant boost in sales. Moreover, Apple’s foray into health tech with the new FDA-approved sleep apnea detection feature for the Apple Watch Series 10 shows that the company is still innovating in other areas. This feature could be a game-changer for millions of people with undiagnosed sleep disorders, opening up a new market segment for Apple’s wearables. Technical Analysis: AAPL’s 3% Decline and Key Support Zones Now, turning to the technical aspect, NASDAQ:AAPL stock is down 3% during Monday’s trading session, marking a pullback from its recent highs. While this decline has raised eyebrows, it’s important to note that Apple’s stock has been in a continuous uptrend since June 2019, showing incredible resilience over the years. The stock's recent decline is partly due to lower-than-expected iPhone 16 pre-orders and broader concerns over its lag in AI innovation. However, NASDAQ:AAPL stock has formed a major support zone at the $125 pivot level. This zone correlates with the consolidation area observed on November 30, 2023, marking a potential bounce point for the stock. The stock’s Relative Strength Index (RSI) is hovering around the mid-50s, suggesting that while the stock isn’t oversold, it’s approaching levels that could attract buyers. Additionally, NASDAQ:AAPL is still trading above several key moving averages, offering further support for a potential reversal. Investors looking for a technical entry point might find this level particularly attractive, especially if the stock can hold the $125 support level and begin to rally. Why Apple Stock May Still Be a Buy Despite weaker pre-orders and concerns about AI innovation, there are several reasons why NASDAQ:AAPL remains a compelling buy at this stage: 1. Strategic Timing: Apple often introduces new features and technologies closer to the holiday season. It’s plausible that the company is withholding some of its most compelling AI advancements for the peak shopping months in November and December. 2. AI Potential: While Apple may currently lag in AI, its history of integrating groundbreaking features into its ecosystem should not be overlooked. If Apple rolls out significant AI updates within the next 12-18 months, it could trigger a renewed interest in its product line and drive stock price appreciation. 3. Long-Term Growth: Apple’s stock has demonstrated long-term growth and resilience, bouncing back from setbacks in the past. Its ability to navigate challenges in China, coupled with a potential holiday-season boost, positions NASDAQ:AAPL for a recovery in 2024. 4. Health Tech Advancements: The FDA’s recent approval of Apple’s sleep apnea detection feature for the Apple Watch further strengthens its position in the health tech market, which could open up a lucrative revenue stream. With 30 million Americans affected by sleep apnea, this feature could see widespread adoption, boosting sales of the Apple Watch Series 10 and Ultra 2 models. Final Thoughts Apple's current dip, driven by weaker iPhone 16 pre-orders and a lack of AI innovation, may present a buying opportunity for long-term investors. While the stock is facing short-term headwinds, its strong fundamentals, history of innovation, and potential AI advancements in the coming months could set the stage for a strong rebound. Investors should closely monitor Apple’s performance in the upcoming holiday season, as this could be a critical period for the company to regain momentum. For now, the $125 support level may provide an ideal entry point for those looking to capitalize on any future upside. As always, it's important to stay informed on new developments and keep an eye on Apple’s evolving strategies, particularly in AI and health tech.by DEXWireNews225
SNDL - bullish exit from Rising Wedge SUNDIAL GROWERS had a bullish break out of a wedge. Volume expanded outwards and converged on the way back to the puter line of the wedge. Now the ice line above 2 USD is tested before I guess it will go up to 8 or 10 USD the next months. Longby revilo1987Updated 14145
Mazdock near monthly supportMazdock is currently trading near monthly support and its rsi is also in oversold area so swing traders or long traders may take their position for long or swing trading.Longby ravimakadia83Updated 119
Sibanye-Stillwater (SBSW) — Huge Move Ahead? (Platinum Miner)Sibanye-Stillwater is one of the world’s largest producers of platinum, palladium, and rhodium. Read more on their website . If you are bullish on platinum, this is a fantastic opportunity. On the weekly chart we can see accumulation has been happening on high volume since it hit support in November 2023. V-shaped recovery on high volume on the daily (for confirmation wait for current week to close above $4): Also last week had the highest volume since 2017. When comparing it with the platinum chart we can see it made very volatile moves in 2016 and 2021 and reached the top at around $20 when platinum did small rallies to $1150-1250 levels. Can you imagine what will happen if platinum makes a new all time high? For additional confirmation wait for trend line breakout: Conservative target is $20 but it can be much more if platinum makes new highs.Longby function_mechanic181811